期刊文献+

经导管主动脉瓣置换术临床应用及管理探讨 被引量:1

Discussion on Clinical Application and Management of Transcatheter Aortic Valve Replacement
下载PDF
导出
摘要 目的追踪经导管主动脉瓣置换术治疗主动脉瓣狭窄的临床应用情况,与外科主动脉瓣置换术进行对比,就提升经导管主动脉瓣置换术管理水平提出建议。方法制定纳入排除标准,系统检索电子病例系统中2016—2019年符合入组条件的病例,进行特征分析。结果 (1)两组在手术时间长度、术后并发症方面的差异具有统计学意义;(2)两组在总费用、药费、诊断费、医用材料费方面的差异具有统计学意义。结论经导管主动脉瓣置换术可以有效地、较安全地应用于主动脉瓣狭窄患者,但其总体费用偏高。 Objective To track the clinical application of transcatheter aortic valve replacement for the treatment of aortic valve stenosis,to compare it with surgical aortic valve replacement,and to propose suggestions for improving the management of transcatheter aortic valve replacement.Methods The cases in electronic medical record system from 2016 to 2019 were screened by certain inclusion and exclusion criteria and feature analysis was conducted.Results(1)There were statistical differences in the length of operation and postoperative complications between the two groups;(2)There were statistical differences in thetotal cost,medicine fee,diagnosis fee,medical consumable fee between the two groups.Conclusion Transcatheter aortic valve replacement is effective and safe for the patients with aortic valve stenosis,but the total cost is relatively high.
作者 李洋 李雪迎 马为 林箐 王平 LI Yang;LI Xue-ying;MA Wei;LIN Jing;WANG Ping(Peking University First Hospital)
出处 《医院管理论坛》 2021年第1期26-28,75,共4页 Hospital Management Forum
关键词 经导管主动脉瓣置换术 医疗技术 临床应用管理 Transcatheter aortic valve replacement Medical technology Clinical application management
  • 相关文献

参考文献5

二级参考文献48

  • 1袁中祥.TAVI手术的现状与展望[J].外科研究与新技术,2014,3(2):88-91. 被引量:5
  • 2Cribier A,Eltchaninoff H,Bash A,et al.Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis:first human case description.Circulation,2002,106:3006-3008.
  • 3Holmes DR Jr,Mack MJ,Kaul S,et al.2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement.J Am Coll Cardiol,2012,59:1200-1254.
  • 4Vahanian A,Alfieri O,Andreotti F,et al.Guidelines on the management of valvular heart disease(version 2012):the joint task force on the management of valvular heart disease of the European Society of Cardiology(ESC)and the European Association for Cardio-Thoracic Surgery(EACTS).Eur Heart J,2012,33:2451-2496.
  • 5Nishimura RA,Otto CM,Bonow RO,et al.2014 AHA/ACC guideline for the management of patients with valvular heart disease:executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol,2014,63:2438-2488.
  • 6Leon MB,Smith CR,Mack M,et al.Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.N Engl J Med,2010,363:1597-1607.
  • 7Stewart BF,Siscovick D,Lind BK,et al.Clinical factors associated with calcific aortic valve disease:Cardiovascular Health Study.J Am Coll Cardiol,1997,29:630-634.
  • 8Otto CM,Lind BK,Kitzman DW,et al.Association of aorticvalve sclerosis with cardiovascular mortality and morbidity in the elderly.N Engl J Med,1999,341:142-147.
  • 9Nkomo VT,Gardin JM,Skelton TN,et al.Burden of valvular heart diseases:a population-based study.Lancet,2006,368:1005-1011.
  • 10Pan W,Zhou D,Cheng L,et al.Candidates for transcatheter aortic valve implantation may be fewer in China.Int J Cardiol,2013,168:e133-134.

共引文献101

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部